Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseases

被引：0
作者：
Cosimo Bruni
Roberta Bitti
Francesca Nacci
Laura Cometi
Lorenzo Tofani
Francesca Bartoli
Ginevra Fiori
Marco Matucci-Cerinic
机构：
[1] University of Firenze,Department of Experimental and Clinical Medicine, Division of Rheumatology
[2] Azienda Ospedaliero Universitaria Careggi,Department of Geriatric Medicine, Division of Rheumatology
来源：
Clinical Rheumatology | 2021年 / 40卷
关键词：
Adalimumab; Axial spondyloarthritis; Psoriatic arthritis; Rheumatoid arthritis; SB5; Switch;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：85 / 91
页数：6
相关论文
共 257 条
[1]  
Scott DL(2010)Rheumatoid arthritis Lancet 376 1094-1108
[2]  
Wolfe F(2017)Psoriatic arthritis N Engl J Med 376 957-970
[3]  
Huizinga TW(2016)Ankylosing spondylitis and axial spondyloarthritis N Engl J Med 374 2563-2574
[4]  
Ritchlin CT(2011)Juvenile idiopathic arthritis Lancet Lond Engl 377 2138-2149
[5]  
Colbert RA(2007)Juvenile idiopathic arthritis Lancet Lond Engl 369 767-778
[6]  
Gladman DD(2016)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update Ann Rheum Dis 76 960-977
[7]  
Taurog JD(2019)A systematic review of guidelines for managing rheumatoid arthritis BMC Rheumatol 3 42-510
[8]  
Chhabra A(2016)European league against rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update Ann Rheum Dis 75 499-2512
[9]  
Colbert RA(2013)2013 update of the 2011 American College of Rheumatology Recommendations for the treatment of juvenile idiopathic arthritis Arthritis Rheum 65 2499-991
[10]  
Prakken B(2017)2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis Ann Rheum Dis 76 978-2284
12345678910